1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Pulmonary Edema Market Size Growth Rate by Type: 2017 VS 2021 VS 2028
1.2.2 Diagnosis
1.2.3 Treatment
1.3 Market by Application
1.3.1 Global Pulmonary Edema Market Share by Application: 2017 VS 2021 VS 2028
1.3.2 Hospitals & Clinics
1.3.3 Academic Institutes
1.3.4 Retail Pharmacies
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Pulmonary Edema Market Perspective (2017-2028)
2.2 Pulmonary Edema Growth Trends by Region
2.2.1 Pulmonary Edema Market Size by Region: 2017 VS 2021 VS 2028
2.2.2 Pulmonary Edema Historic Market Size by Region (2017-2022)
2.2.3 Pulmonary Edema Forecasted Market Size by Region (2023-2028)
2.3 Pulmonary Edema Market Dynamics
2.3.1 Pulmonary Edema Industry Trends
2.3.2 Pulmonary Edema Market Drivers
2.3.3 Pulmonary Edema Market Challenges
2.3.4 Pulmonary Edema Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Pulmonary Edema Players by Revenue
3.1.1 Global Top Pulmonary Edema Players by Revenue (2017-2022)
3.1.2 Global Pulmonary Edema Revenue Market Share by Players (2017-2022)
3.2 Global Pulmonary Edema Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Pulmonary Edema Revenue
3.4 Global Pulmonary Edema Market Concentration Ratio
3.4.1 Global Pulmonary Edema Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Pulmonary Edema Revenue in 2021
3.5 Pulmonary Edema Key Players Head office and Area Served
3.6 Key Players Pulmonary Edema Product Solution and Service
3.7 Date of Enter into Pulmonary Edema Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Pulmonary Edema Breakdown Data by Type
4.1 Global Pulmonary Edema Historic Market Size by Type (2017-2022)
4.2 Global Pulmonary Edema Forecasted Market Size by Type (2023-2028)
5 Pulmonary Edema Breakdown Data by Application
5.1 Global Pulmonary Edema Historic Market Size by Application (2017-2022)
5.2 Global Pulmonary Edema Forecasted Market Size by Application (2023-2028)
6 North America
6.1 North America Pulmonary Edema Market Size (2017-2028)
6.2 North America Pulmonary Edema Market Size by Country (2017-2022)
6.3 North America Pulmonary Edema Market Size by Country (2023-2028)
6.4 United States
6.5 Canada
7 Europe
7.1 Europe Pulmonary Edema Market Size (2017-2028)
7.2 Europe Pulmonary Edema Market Size by Country (2017-2022)
7.3 Europe Pulmonary Edema Market Size by Country (2023-2028)
7.4 Germany
7.5 France
7.6 U.K.
7.7 Italy
7.8 Russia
7.9 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Pulmonary Edema Market Size (2017-2028)
8.2 Asia-Pacific Pulmonary Edema Market Size by Country (2017-2022)
8.3 Asia-Pacific Pulmonary Edema Market Size by Country (2023-2028)
8.4 China
8.5 Japan
8.6 South Korea
8.7 Southeast Asia
8.8 India
8.9 Australia
9 Latin America
9.1 Latin America Pulmonary Edema Market Size (2017-2028)
9.2 Latin America Pulmonary Edema Market Size by Country (2017-2022)
9.3 Latin America Pulmonary Edema Market Size by Country (2023-2028)
9.4 Mexico
9.5 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Pulmonary Edema Market Size (2017-2028)
10.2 Middle East & Africa Pulmonary Edema Market Size by Country (2017-2022)
10.3 Middle East & Africa Pulmonary Edema Market Size by Country (2023-2028)
10.4 Turkey
10.5 Saudi Arabia
10.6 UAE
11 Key Players Profiles
11.1 Pfizer Inc. (US)
11.1.1 Pfizer Inc. (US) Company Detail
11.1.2 Pfizer Inc. (US) Business Overview
11.1.3 Pfizer Inc. (US) Pulmonary Edema Introduction
11.1.4 Pfizer Inc. (US) Revenue in Pulmonary Edema Business (2017-2022)
11.1.5 Pfizer Inc. (US) Recent Development
11.2 ARGON MEDICAL (US)
11.2.1 ARGON MEDICAL (US) Company Detail
11.2.2 ARGON MEDICAL (US) Business Overview
11.2.3 ARGON MEDICAL (US) Pulmonary Edema Introduction
11.2.4 ARGON MEDICAL (US) Revenue in Pulmonary Edema Business (2017-2022)
11.2.5 ARGON MEDICAL (US) Recent Development
11.3 Edwards Lifesciences Corporation (US)
11.3.1 Edwards Lifesciences Corporation (US) Company Detail
11.3.2 Edwards Lifesciences Corporation (US) Business Overview
11.3.3 Edwards Lifesciences Corporation (US) Pulmonary Edema Introduction
11.3.4 Edwards Lifesciences Corporation (US) Revenue in Pulmonary Edema Business (2017-2022)
11.3.5 Edwards Lifesciences Corporation (US) Recent Development
11.4 BD (US)
11.4.1 BD (US) Company Detail
11.4.2 BD (US) Business Overview
11.4.3 BD (US) Pulmonary Edema Introduction
11.4.4 BD (US) Revenue in Pulmonary Edema Business (2017-2022)
11.4.5 BD (US) Recent Development
11.5 Alcaliber S.A. (Spain)
11.5.1 Alcaliber S.A. (Spain) Company Detail
11.5.2 Alcaliber S.A. (Spain) Business Overview
11.5.3 Alcaliber S.A. (Spain) Pulmonary Edema Introduction
11.5.4 Alcaliber S.A. (Spain) Revenue in Pulmonary Edema Business (2017-2022)
11.5.5 Alcaliber S.A. (Spain) Recent Development
11.6 Lupin Pharmaceuticals(India)
11.6.1 Lupin Pharmaceuticals(India) Company Detail
11.6.2 Lupin Pharmaceuticals(India) Business Overview
11.6.3 Lupin Pharmaceuticals(India) Pulmonary Edema Introduction
11.6.4 Lupin Pharmaceuticals(India) Revenue in Pulmonary Edema Business (2017-2022)
11.6.5 Lupin Pharmaceuticals(India) Recent Development
11.7 Vitaltec Corporation (China)
11.7.1 Vitaltec Corporation (China) Company Detail
11.7.2 Vitaltec Corporation (China) Business Overview
11.7.3 Vitaltec Corporation (China) Pulmonary Edema Introduction
11.7.4 Vitaltec Corporation (China) Revenue in Pulmonary Edema Business (2017-2022)
11.7.5 Vitaltec Corporation (China) Recent Development
11.8 Medtronic (US)
11.8.1 Medtronic (US) Company Detail
11.8.2 Medtronic (US) Business Overview
11.8.3 Medtronic (US) Pulmonary Edema Introduction
11.8.4 Medtronic (US) Revenue in Pulmonary Edema Business (2017-2022)
11.8.5 Medtronic (US) Recent Development
11.9 Koninklijke Philips N.V. (The Netherlands)
11.9.1 Koninklijke Philips N.V. (The Netherlands) Company Detail
11.9.2 Koninklijke Philips N.V. (The Netherlands) Business Overview
11.9.3 Koninklijke Philips N.V. (The Netherlands) Pulmonary Edema Introduction
11.9.4 Koninklijke Philips N.V. (The Netherlands) Revenue in Pulmonary Edema Business (2017-2022)
11.9.5 Koninklijke Philips N.V. (The Netherlands) Recent Development
11.10 Siemens Healthcare GmbH (Germany)
11.10.1 Siemens Healthcare GmbH (Germany) Company Detail
11.10.2 Siemens Healthcare GmbH (Germany) Business Overview
11.10.3 Siemens Healthcare GmbH (Germany) Pulmonary Edema Introduction
11.10.4 Siemens Healthcare GmbH (Germany) Revenue in Pulmonary Edema Business (2017-2022)
11.10.5 Siemens Healthcare GmbH (Germany) Recent Development
11.11 Hitachi Medical Corporation (US)
11.11.1 Hitachi Medical Corporation (US) Company Detail
11.11.2 Hitachi Medical Corporation (US) Business Overview
11.11.3 Hitachi Medical Corporation (US) Pulmonary Edema Introduction
11.11.4 Hitachi Medical Corporation (US) Revenue in Pulmonary Edema Business (2017-2022)
11.11.5 Hitachi Medical Corporation (US) Recent Development
11.12 Canon Medical Systems Corporation (Japan)
11.12.1 Canon Medical Systems Corporation (Japan) Company Detail
11.12.2 Canon Medical Systems Corporation (Japan) Business Overview
11.12.3 Canon Medical Systems Corporation (Japan) Pulmonary Edema Introduction
11.12.4 Canon Medical Systems Corporation (Japan) Revenue in Pulmonary Edema Business (2017-2022)
11.12.5 Canon Medical Systems Corporation (Japan) Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of Tables
Table 1. Global Pulmonary Edema Market Size Growth Rate by Type (US$ Million): 2017 VS 2021 VS 2028
Table 2. Key Players of Diagnosis
Table 3. Key Players of Treatment
Table 4. Global Pulmonary Edema Market Size Growth by Application (US$ Million): 2017 VS 2021 VS 2028
Table 5. Global Pulmonary Edema Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
Table 6. Global Pulmonary Edema Market Size by Region (2017-2022) & (US$ Million)
Table 7. Global Pulmonary Edema Market Share by Region (2017-2022)
Table 8. Global Pulmonary Edema Forecasted Market Size by Region (2023-2028) & (US$ Million)
Table 9. Global Pulmonary Edema Market Share by Region (2023-2028)
Table 10. Pulmonary Edema Market Trends
Table 11. Pulmonary Edema Market Drivers
Table 12. Pulmonary Edema Market Challenges
Table 13. Pulmonary Edema Market Restraints
Table 14. Global Pulmonary Edema Revenue by Players (2017-2022) & (US$ Million)
Table 15. Global Pulmonary Edema Market Share by Players (2017-2022)
Table 16. Global Top Pulmonary Edema Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Pulmonary Edema as of 2021)
Table 17. Ranking of Global Top Pulmonary Edema Companies by Revenue (US$ Million) in 2021
Table 18. Global 5 Largest Players Market Share by Pulmonary Edema Revenue (CR5 and HHI) & (2017-2022)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Pulmonary Edema Product Solution and Service
Table 21. Date of Enter into Pulmonary Edema Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Pulmonary Edema Market Size by Type (2017-2022) & (US$ Million)
Table 24. Global Pulmonary Edema Revenue Market Share by Type (2017-2022)
Table 25. Global Pulmonary Edema Forecasted Market Size by Type (2023-2028) & (US$ Million)
Table 26. Global Pulmonary Edema Revenue Market Share by Type (2023-2028)
Table 27. Global Pulmonary Edema Market Size by Application (2017-2022) & (US$ Million)
Table 28. Global Pulmonary Edema Revenue Market Share by Application (2017-2022)
Table 29. Global Pulmonary Edema Forecasted Market Size by Application (2023-2028) & (US$ Million)
Table 30. Global Pulmonary Edema Revenue Market Share by Application (2023-2028)
Table 31. North America Pulmonary Edema Market Size by Country (2017-2022) & (US$ Million)
Table 32. North America Pulmonary Edema Market Size by Country (2023-2028) & (US$ Million)
Table 33. Europe Pulmonary Edema Market Size by Country (2017-2022) & (US$ Million)
Table 34. Europe Pulmonary Edema Market Size by Country (2023-2028) & (US$ Million)
Table 35. Asia-Pacific Pulmonary Edema Market Size by Region (2017-2022) & (US$ Million)
Table 36. Asia-Pacific Pulmonary Edema Market Size by Region (2023-2028) & (US$ Million)
Table 37. Latin America Pulmonary Edema Market Size by Country (2017-2022) & (US$ Million)
Table 38. Latin America Pulmonary Edema Market Size by Country (2023-2028) & (US$ Million)
Table 39. Middle East & Africa Pulmonary Edema Market Size by Country (2017-2022) & (US$ Million)
Table 40. Middle East & Africa Pulmonary Edema Market Size by Country (2023-2028) & (US$ Million)
Table 41. Pfizer Inc. (US) Company Detail
Table 42. Pfizer Inc. (US) Business Overview
Table 43. Pfizer Inc. (US) Pulmonary Edema Product
Table 44. Pfizer Inc. (US) Revenue in Pulmonary Edema Business (2017-2022) & (US$ Million)
Table 45. Pfizer Inc. (US) Recent Development
Table 46. ARGON MEDICAL (US) Company Detail
Table 47. ARGON MEDICAL (US) Business Overview
Table 48. ARGON MEDICAL (US) Pulmonary Edema Product
Table 49. ARGON MEDICAL (US) Revenue in Pulmonary Edema Business (2017-2022) & (US$ Million)
Table 50. ARGON MEDICAL (US) Recent Development
Table 51. Edwards Lifesciences Corporation (US) Company Detail
Table 52. Edwards Lifesciences Corporation (US) Business Overview
Table 53. Edwards Lifesciences Corporation (US) Pulmonary Edema Product
Table 54. Edwards Lifesciences Corporation (US) Revenue in Pulmonary Edema Business (2017-2022) & (US$ Million)
Table 55. Edwards Lifesciences Corporation (US) Recent Development
Table 56. BD (US) Company Detail
Table 57. BD (US) Business Overview
Table 58. BD (US) Pulmonary Edema Product
Table 59. BD (US) Revenue in Pulmonary Edema Business (2017-2022) & (US$ Million)
Table 60. BD (US) Recent Development
Table 61. Alcaliber S.A. (Spain) Company Detail
Table 62. Alcaliber S.A. (Spain) Business Overview
Table 63. Alcaliber S.A. (Spain) Pulmonary Edema Product
Table 64. Alcaliber S.A. (Spain) Revenue in Pulmonary Edema Business (2017-2022) & (US$ Million)
Table 65. Alcaliber S.A. (Spain) Recent Development
Table 66. Lupin Pharmaceuticals(India) Company Detail
Table 67. Lupin Pharmaceuticals(India) Business Overview
Table 68. Lupin Pharmaceuticals(India) Pulmonary Edema Product
Table 69. Lupin Pharmaceuticals(India) Revenue in Pulmonary Edema Business (2017-2022) & (US$ Million)
Table 70. Lupin Pharmaceuticals(India) Recent Development
Table 71. Vitaltec Corporation (China) Company Detail
Table 72. Vitaltec Corporation (China) Business Overview
Table 73. Vitaltec Corporation (China) Pulmonary Edema Product
Table 74. Vitaltec Corporation (China) Revenue in Pulmonary Edema Business (2017-2022) & (US$ Million)
Table 75. Vitaltec Corporation (China) Recent Development
Table 76. Medtronic (US) Company Detail
Table 77. Medtronic (US) Business Overview
Table 78. Medtronic (US) Pulmonary Edema Product
Table 79. Medtronic (US) Revenue in Pulmonary Edema Business (2017-2022) & (US$ Million)
Table 80. Medtronic (US) Recent Development
Table 81. Koninklijke Philips N.V. (The Netherlands) Company Detail
Table 82. Koninklijke Philips N.V. (The Netherlands) Business Overview
Table 83. Koninklijke Philips N.V. (The Netherlands) Pulmonary Edema Product
Table 84. Koninklijke Philips N.V. (The Netherlands) Revenue in Pulmonary Edema Business (2017-2022) & (US$ Million)
Table 85. Koninklijke Philips N.V. (The Netherlands) Recent Development
Table 86. Siemens Healthcare GmbH (Germany) Company Detail
Table 87. Siemens Healthcare GmbH (Germany) Business Overview
Table 88. Siemens Healthcare GmbH (Germany) Pulmonary Edema Product
Table 89. Siemens Healthcare GmbH (Germany) Revenue in Pulmonary Edema Business (2017-2022) & (US$ Million)
Table 90. Siemens Healthcare GmbH (Germany) Recent Development
Table 91. Hitachi Medical Corporation (US) Company Detail
Table 92. Hitachi Medical Corporation (US) Business Overview
Table 93. Hitachi Medical Corporation (US) Pulmonary EdemaProduct
Table 94. Hitachi Medical Corporation (US) Revenue in Pulmonary Edema Business (2017-2022) & (US$ Million)
Table 95. Hitachi Medical Corporation (US) Recent Development
Table 96. Canon Medical Systems Corporation (Japan) Company Detail
Table 97. Canon Medical Systems Corporation (Japan) Business Overview
Table 98. Canon Medical Systems Corporation (Japan) Pulmonary EdemaProduct
Table 99. Canon Medical Systems Corporation (Japan) Revenue in Pulmonary Edema Business (2017-2022) & (US$ Million)
Table 100. Canon Medical Systems Corporation (Japan) Recent Development
Table 101. Research Programs/Design for This Report
Table 102. Key Data Information from Secondary Sources
Table 103. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Pulmonary Edema Market Share by Type: 2021 VS 2028
Figure 2. Diagnosis Features
Figure 3. Treatment Features
Figure 4. Global Pulmonary Edema Market Share by Application in 2021 & 2028
Figure 5. Hospitals & Clinics Case Studies
Figure 6. Academic Institutes Case Studies
Figure 7. Retail Pharmacies Case Studies
Figure 8. Pulmonary Edema Report Years Considered
Figure 9. Global Pulmonary Edema Market Size (US$ Million), Year-over-Year: 2017-2028
Figure 10. Global Pulmonary Edema Market Size, (US$ Million), 2017 VS 2021 VS 2028
Figure 11. Global Pulmonary Edema Market Share by Region: 2021 VS 2028
Figure 12. Global Pulmonary Edema Market Share by Players in 2021
Figure 13. Global Top Pulmonary Edema Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Pulmonary Edema as of 2021)
Figure 14. The Top 10 and 5 Players Market Share by Pulmonary Edema Revenue in 2021
Figure 15. North America Pulmonary Edema Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 16. North America Pulmonary Edema Market Share by Country (2017-2028)
Figure 17. United States Pulmonary Edema Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 18. Canada Pulmonary Edema Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 19. Europe Pulmonary Edema Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 20. Europe Pulmonary Edema Market Share by Country (2017-2028)
Figure 21. Germany Pulmonary Edema Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 22. France Pulmonary Edema Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 23. U.K. Pulmonary Edema Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 24. Italy Pulmonary Edema Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 25. Russia Pulmonary Edema Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 26. Nordic Countries Pulmonary Edema Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 27. Asia-Pacific Pulmonary Edema Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 28. Asia-Pacific Pulmonary Edema Market Share by Region (2017-2028)
Figure 29. China Pulmonary Edema Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 30. Japan Pulmonary Edema Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 31. South Korea Pulmonary Edema Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 32. Southeast Asia Pulmonary Edema Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 33. India Pulmonary Edema Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 34. Australia Pulmonary Edema Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 35. Latin America Pulmonary Edema Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 36. Latin America Pulmonary Edema Market Share by Country (2017-2028)
Figure 37. Mexico Pulmonary Edema Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 38. Brazil Pulmonary Edema Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 39. Middle East & Africa Pulmonary Edema Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 40. Middle East & Africa Pulmonary Edema Market Share by Country (2017-2028)
Figure 41. Turkey Pulmonary Edema Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 42. Saudi Arabia Pulmonary Edema Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 43. Pfizer Inc. (US) Revenue Growth Rate in Pulmonary Edema Business (2017-2022)
Figure 44. ARGON MEDICAL (US) Revenue Growth Rate in Pulmonary Edema Business (2017-2022)
Figure 45. Edwards Lifesciences Corporation (US) Revenue Growth Rate in Pulmonary Edema Business (2017-2022)
Figure 46. BD (US) Revenue Growth Rate in Pulmonary Edema Business (2017-2022)
Figure 47. Alcaliber S.A. (Spain) Revenue Growth Rate in Pulmonary Edema Business (2017-2022)
Figure 48. Lupin Pharmaceuticals(India) Revenue Growth Rate in Pulmonary Edema Business (2017-2022)
Figure 49. Vitaltec Corporation (China) Revenue Growth Rate in Pulmonary Edema Business (2017-2022)
Figure 50. Medtronic (US) Revenue Growth Rate in Pulmonary Edema Business (2017-2022)
Figure 51. Koninklijke Philips N.V. (The Netherlands) Revenue Growth Rate in Pulmonary Edema Business (2017-2022)
Figure 52. Siemens Healthcare GmbH (Germany) Revenue Growth Rate in Pulmonary Edema Business (2017-2022)
Figure 53. Hitachi Medical Corporation (US) Revenue Growth Rate in Pulmonary Edema Business (2017-2022)
Figure 54. Canon Medical Systems Corporation (Japan) Revenue Growth Rate in Pulmonary Edema Business (2017-2022)
Figure 55. Bottom-up and Top-down Approaches for This Report
Figure 56. Data Triangulation
Figure 57. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Pfizer Inc. (US) ARGON MEDICAL (US) Edwards Lifesciences Corporation (US) BD (US) Alcaliber S.A. (Spain) Lupin Pharmaceuticals(India) Vitaltec Corporation (China) Medtronic (US) Koninklijke Philips N.V. (The Netherlands) Siemens Healthcare GmbH (Germany) Hitachi Medical Corporation (US) Canon Medical Systems Corporation (Japan)